Corcept Therapeutics Inc (CORT)

11.98
NASDAQ : Health Care
Prev Close 11.98
Day Low/High 0.00 / 0.00
52 Wk Low/High 5.24 / 12.74
Avg Volume 1.07M
Exchange NASDAQ
Shares Outstanding 113.19M
Market Cap 1.32B
EPS 0.10
P/E Ratio 106.27
Div & Yield N.A. (N.A)

Latest News

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: CHUY, CMCM, CORT, ETSY, EVH, GLPI, HIIQ, PPG, RSPP, SBR, SKYW Downgrades: ALSK, COMM, FOX, MATX, STFC, WINS Initiations: AKTS, QHC, SCWX Read on to get TheStreet Quant Ratings' detailed report:

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ARE, FNFV, GLBZ, SLM, UFPT, YY Downgrades: AFSI, CORT, CUTR, SID, SYF, TIS Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

First Week of June 16th Options Trading For Corcept Therapeutics (CORT)

Investors in Corcept Therapeutics Inc saw new options become available this week, for the June 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CORT options chain for the new June 16th contracts and identified one put and one call contract of particular interest.

Corcept Therapeutics Reaches Analyst Target Price

In recent trading, shares of Corcept Therapeutics Inc have crossed above the average analyst 12-month target price of $10.75, changing hands for $11.10/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

First Week of November 17th Options Trading For Corcept Therapeutics (CORT)

Investors in Corcept Therapeutics Inc saw new options begin trading this week, for the November 17th expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 241 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Corcept Therapeutices Eyes Another Double

Corcept Therapeutices Eyes Another Double

Biotech has a base pattern than can support a lot more upside..

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: CORT, GCAP, VC Downgrades: AXU, FNHC, KBR, MOV, SUI Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

CORT Crosses Above Average Analyst Target

In recent trading, shares of Corcept Therapeutics Inc have crossed above the average analyst 12-month target price of $8.75, changing hands for $8.85/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

Corcept Therapeutics is Now Oversold (CORT)

Corcept Therapeutics is Now Oversold (CORT)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Interesting CORT Put And Call Options For August 2017

Interesting CORT Put And Call Options For August 2017

Investors in Corcept Therapeutics Inc saw new options become available this week, for the August 2017 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 240 days until expiration the newly available contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Commit To Purchase Corcept Therapeutics At $7, Earn 10.8% Annualized Using Options

Commit To Purchase Corcept Therapeutics At $7, Earn 10.8% Annualized Using Options

Investors considering a purchase of Corcept Therapeutics Inc shares, but cautious about paying the going market price of $8.22/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the May 2017 put at the $7 strike, which has a bid at the time of this writing of 40 cents.

5 Stocks Under $10 That Could Make You a Lot of Money

5 Stocks Under $10 That Could Make You a Lot of Money

These under-$10 stocks are within range of triggering big breakouts. Here's how to trade them now.

Everybody's Doing It: 5 Stocks Under $10 That I Like

Everybody's Doing It: 5 Stocks Under $10 That I Like

These have positive momentum and good growth.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: CORT, CVGI, EPD, EXAR, GAIA, ORIG Downgrades: CMO, DCI, ESP, FCFS, FSLR, OA, PLAB, SR Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Short Interest Increases 35.2% For CORT

Short Interest Increases 35.2% For CORT

The most recent short interest data has been released by the NASDAQ for the 12/31/2015 settlement date, which shows a 1,176,495 share increase in total short interest for Corcept Therapeutics Inc , to 4,521,614, an increase of 35.17% since 12/15/2015. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Insider Trading Alert - RT, CORT And LAYN Traded By Insiders

Insider Trading Alert - RT, CORT And LAYN Traded By Insiders

Stocks with insider trader activity include RT, CORT and LAYN

Insider Trading Alert - CORT, PANW And EQIX Traded By Insiders

Insider Trading Alert - CORT, PANW And EQIX Traded By Insiders

Stocks with insider trader activity include CORT, PANW and EQIX

Insider Trading Alert - SPLK, CMCT And CORT Traded By Insiders

Insider Trading Alert - SPLK, CMCT And CORT Traded By Insiders

Stocks with insider trader activity include SPLK, CMCT and CORT

First Week of CORT May 2016 Options Trading

First Week of CORT May 2016 Options Trading

Investors in Corcept Therapeutics Inc saw new options begin trading this week, for the May 2016 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 233 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

First Week of October 16th Options Trading For Corcept Therapeutics (CORT)

First Week of October 16th Options Trading For Corcept Therapeutics (CORT)

Investors in Corcept Therapeutics Inc saw new options become available this week, for the October 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CORT options chain for the new October 16th contracts and identified the following put contract of particular interest.

Exploring Potential Portfolio Additions

With 21% of the model portfolio in cash, a variety of names are on our radar.

3 Pharmaceutical Stocks to Sell Now

3 Pharmaceutical Stocks to Sell Now

Pharmaceutical companies face increased risks if they do not have enough new drugs in the pipeline to replace those with expiring patents.

Quant Picks: 3 Pharmaceutical Companies to Sell Right Now

Quant Picks: 3 Pharmaceutical Companies to Sell Right Now

Here are some of the worst companies TheStreet Quant Ratings says you should consider selling.

Interesting CORT Put And Call Options For February 2016

Interesting CORT Put And Call Options For February 2016

Investors in Corcept Therapeutics Inc saw new options become available this week, for the February 2016 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 241 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Where the Money Was Made the Last 5 Years

Only one fund category (of 20) has beaten the S&P 500 over half a decade.

Fly Watch: Several Names That May Move Following ASCO Meeting

Fly Watch: Several Names That May Move Following ASCO Meeting

The American Society of Clinical Oncology, or ASCO, is holding the society's 51st annual meeting from May 29 to June 2 in Chicago, Illinois.

Corcept Therapeutics (CORT) Strong On High Relative Volume Today

Corcept Therapeutics (CORT) Strong On High Relative Volume Today

Trade-Ideas LLC identified Corcept Therapeutics (CORT) as a strong on high relative volume candidate

Cortendo AB Joins National Organization For Rare Disorders (NORD)® Corporate Council

Cortendo AB Joins National Organization For Rare Disorders (NORD)® Corporate Council

Leaders in Rare Disease Community Unite for National Cushing's Syndrome Awareness Day on April 8